跳至主要内容
临床试验/NCT06580860
NCT06580860招募中不适用

Psychiatric Multi-omics and Neuroimaging Project Database

mingjun Zhong1 个研究点 分布在 1 个国家目标入组 1,899 人开始时间: 2016年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,899
试验地点
1
主要终点
cortical morphology

研究概览

简要总结

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.

详细描述

The study seeks to identify possible biological markers of schizophrenia and the effects of gene-environment interactions on brain structural and functional networks. So we can help doctors and scientific researchers better understand the neuropathological basis of schizophrenia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
13 Years 至 35 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)
  • Course of disease: <24 months
  • Priority is given to patients who have never taken medicine or duration of drug use < 2 weeks
  • No nuclear magnetic contraindications.

排除标准

  • Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence
  • Have a major physical disease or infectious disease
  • History of coma and serious neurological disease 4.MRI contraindications.

研究组 & 干预措施

PMNP-Healthy Norms

Healthy Norms

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

PMNP-Subclinical high-risk

Subclinical high-risk

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

PMNP-Schizophrenia and Psychosis

Schizophrenia and Psychosis patient

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

PMNP-MDD

major depressive disorder patient

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

PMNP-ASD

autism spectrum disorder patient

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

PMNP-BD

bipolar disorder patient

干预措施: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids (Drug)

结局指标

主要结局

cortical morphology

时间窗: 40 minutes

Data were obtained using magnetic resonance scans

target gene charaacteristics

时间窗: 1 day

10ml peripheral blood was extracted for gene analysis

scale scores

时间窗: 90 minutes.

The score of each dimension and the total score were calculated according to the scale.The scale includes three dimensions: negative symptom, positive symptom and general psychopathology, and the score range of each dimension is different. The total score ranges from 30 to 210, with higher scores indicating worse results.

次要结局

未报告次要终点

研究者

发起方
mingjun Zhong
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

mingjun Zhong

Principal Investigator

Second Xiangya Hospital of Central South University

研究点 (1)

Loading locations...

相似试验